Friday, June 26, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 819 of 1,261

  1. US 8710030

    Phosphonate compounds

    The Regents of the University of California · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  2. US 8710026

    MiR 204, miR 211, their anti-miRs, and therapeutic uses of same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  3. US 8710004

    Stable liquid VEGF antagonist formulations

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  4. US 8709784

    Use of Lactobacillus for liver protection

    China Medical University · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  5. US 8710017

    Human and mouse targeting peptides identified by phage display

    The Board of Regents of the University of Texas System · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  6. US 8709995

    Method for eliciting an immune response to human telomerase reverse transcriptase

    The Regents of the University of Colorado · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  7. US 8709478

    Once daily formulations of tetracyclines

    Supernus Pharmaceuticals, Inc. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  8. US 8709476

    Compositions of quaternary ammonium compounds containing bioavailability enhancers

    Supernus Pharmaceuticals, Inc. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  9. US 8709487

    Nanoparticle entrapment of materials

    The United States of America as represented by the Secretary of the Army · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  10. US 8709774

    Sperm factor sequences

    University College Cardiff Consultants Limited · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  11. US 8703727

    Nanotechnology formulation of poorly soluble compounds

    Aphios Corporation · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  12. US 8703208

    Nanometer mesoporous silica-based xerogel styptic process and its preparing process and application

    East China University of Science and Technology · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  13. US 8703726

    Methods for treating prostate conditions

    PTC THERAPEUTICS, INC. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  14. US 8703115

    Methods for preparing conjugates

    Nektar Therapeutics · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  15. US 8703140

    Inhibition of factor B, the alternative complement pathway and methods related thereto

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  16. US 8703136

    Complement inhibition for improved nerve regeneration

    REGENESANCE B.V. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  17. US 8703134

    Targeted cryptosporidium biocides

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  18. US 8703186

    Abuse-resistant oral dosage forms and method of use thereof

    Elite Laboratories, Inc. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  19. US 8703489

    Methods and compositions for targeted single-stranded cleavage and targeted integration

    Sangamo Biosciences, Inc. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  20. US 8703200

    Inhibition of neovascularization by cerium oxide nanoparticles

    The Board of Regents of the University of Oklahoma · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  21. US 8703826

    Preparation of (R,R)-fenoterol and (R,R)-or (R,S)-fenoterol analogues and their use in treating congestive heart failure

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  22. US 8703800

    Nitrate and diazeniumdiolate derivatives of pioglitazone

    CARDIOLYNX AG · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  23. US 8703791

    3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  24. US 8703735

    Antisense antiviral compounds and methods for treating a filovirus infection

    Sarepta Therapeutics, Inc. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.